Seeking Alpha

Alexion Pharmaceuticals (ALXN) agrees to buy privately-held biotech firm Enobia for $1.08B in...

Alexion Pharmaceuticals (ALXN) agrees to buy privately-held biotech firm Enobia for $1.08B in cash - with $610M paid up front and the rest after various regulatory and sales milestones are hit. Enobia is focused on therapies treating patients with ultra-rare, life-threatening genetic disorders. Shares -1.3% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|